|
Volumn 78, Issue 2, 2011, Pages 137-141
|
[Neuroendocrine target therapies for prostate cancer].;" Neuroendocrine target therapies" per il carcinoma prostatico.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOPEPTIN;
ANTINEOPLASTIC AGENT;
CHROMOGRANIN A;
CYCLOPEPTIDE;
DRUG DERIVATIVE;
ETHINYLESTRADIOL;
SOMATOSTATIN;
TUMOR MARKER;
ARTICLE;
BLOOD;
DISEASE COURSE;
DRUG EFFECT;
HUMAN;
MALE;
NEUROENDOCRINE TUMOR;
PROSTATE TUMOR;
SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHROMOGRANIN A;
DISEASE PROGRESSION;
ETHINYL ESTRADIOL;
HUMANS;
MALE;
NEUROENDOCRINE TUMORS;
PEPTIDES, CYCLIC;
PROSTATIC NEOPLASMS;
SOMATOSTATIN;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 81755166698
PISSN: 03915603
EISSN: None
Source Type: Journal
DOI: 10.5301/RU.2011.8335 Document Type: Article |
Times cited : (4)
|
References (0)
|